The important dividing line is January 1, 2026. The Department of Health and Human Services published the Office of Research Integrity’s final rule on September 17, 2024. The rule became effective January 1, 2025, but its regulatory requirements apply to allegations received by institutions on or after January 1, 2026.

Allegations received before January 1, 2026, generally remain subject to the 2005 version of 42 CFR Part 93. The institution and respondent may instead elect in writing to use the revised rule.

Who is covered

The framework applies to institutions that apply for or receive Public Health Service support for biomedical or behavioral research, related research training, or activities connected with that work. It covers allegations involving applications and proposals, supported research, research records, training programs and related activities.

That includes many NIH-supported projects, but it is not an NIH-only rule. The operative question is whether the research or related activity falls within the Public Health Service framework and its coverage requirements.

What counts as research misconduct

The rule is not a prohibition on flawed, controversial or unpopular science. It defines research misconduct as fabrication, falsification or plagiarism in proposing, performing or reviewing research, or in reporting research results.

Fabrication means making up data or results and recording or reporting them. Falsification involves manipulating research materials, equipment or processes, or changing or omitting data or results so the research is not accurately represented in the research record. Plagiarism is using another person’s ideas, processes, results or words without appropriate credit.

The rule excludes honest error and differences of opinion. A finding also requires three additional elements: a significant departure from accepted practices in the relevant research community, intentional, knowing or reckless conduct, and proof by a preponderance of the evidence.

How a case moves forward

Covered institutions must maintain written policies and procedures and respond in a thorough, competent, objective and fair manner. They must address conflicts of interest, protect relevant records and take reasonable and practical steps to protect good-faith complainants, witnesses and committee members from retaliation.

The first stage is an institutional assessment. The institution must document the assessment and retain enough information to explain why the matter was closed or advanced. If an inquiry is warranted, the institution must obtain or sequester the research records and other evidence needed for the proceeding.

An inquiry is a preliminary review of whether an allegation falls within the rule and may have substance. It generally must be completed within 90 days. If it takes longer, the inquiry report must explain why. The respondent must receive notice, a copy of the inquiry report and an opportunity to comment. A finding of misconduct cannot be made at the inquiry stage.

An investigation is warranted when there is a reasonable basis to conclude that the allegation involves covered PHS-supported research and that preliminary fact-finding indicates the allegation may have substance. The institution must notify ORI within 30 days of deciding that an investigation is warranted and provide the inquiry report and specified supporting information.

What institutions must document

During an investigation, institutions must obtain the research records and other evidence needed to reach a decision, examine relevant evidence, use people with appropriate scientific expertise and take reasonable steps to avoid unresolved conflicts of interest.

The institution must interview the respondent, the complainant and other reasonably identified people with relevant information, including witnesses identified by the respondent. Investigation interviews must be recorded and transcribed. Interviewees must be given the transcript for correction, and the corrected transcripts and numbered exhibits become part of the institutional record.

The respondent may not attend witnesses’ interviews but must receive a transcript of those interviews. The respondent also must receive the draft investigation report and access to the research records and evidence considered by the committee, subject to the rule’s procedures. The respondent generally has 30 days to comment on the draft report.

The institution must complete all aspects of an investigation within 180 days unless ORI grants an extension. If more time is needed, the institution must request an extension in writing and explain the circumstances warranting it.

Protections and confidentiality limits

The rule gives respondents opportunities to answer allegations and comment on reports. Decision-makers must consider admissible, credible evidence of honest error or a difference of opinion when evaluating the case.

During a proceeding, disclosure of the identities of respondents, complainants and witnesses is limited, as far as possible, to people who need to know and as allowed by law. That group may include institutional review boards, journals, editors, publishers, co-authors and collaborating institutions. Records that could identify research subjects receive additional confidentiality protection.

Confidentiality is not absolute. The rule permits institutions to manage published data or acknowledge that data may be unreliable, and institutions must provide information to ORI during federal oversight. The rule also does not require every institutional proceeding to be publicly disclosed.

Institutions must take reasonable and practical steps to protect good-faith complainants, witnesses and committee members from retaliation. Those protections do not guarantee anonymity or eliminate the possibility of workplace, professional or legal consequences when a matter is reported.

Why the rule matters beyond universities

Research-misconduct proceedings can affect patients, research participants, taxpayers and the public when unreliable data enter publications, grant applications, clinical research or public-health decision-making. The rule allows institutions and ORI to address potential risks to public health, research subjects, public safety, federal resources or possible legal violations through the applicable federal processes.

Institutions were required to update their written policies and procedures and submit revised policies with the annual report covering the 2025 reporting year, due April 30, 2026. For current cases, the practical result is a more explicit paper trail: institutions must document assessments, preserve evidence, report decisions to open investigations, record and transcribe investigation interviews, and maintain records that ORI can review.

ORI retains federal oversight authority, but it does not automatically redo every institutional investigation. Institutions have primary responsibility for the initial assessment, inquiry and investigation, while HHS may review the institutional record, conduct its own work when authorized and take appropriate administrative action.

What researchers should check

Researchers supported primarily by the National Science Foundation should not assume this HHS process applies. NSF uses its own research-misconduct regulation for NSF-funded work and directs allegations involving NSF applicants and awardees to its Office of Inspector General.

For researchers and institutions, the first practical question in a new case is therefore not simply whether NIH money was involved. It is which federal agency’s rules apply, when the allegation was received, whether the conduct fits the narrow federal definition of research misconduct, and what records must be preserved from the outset.

Sources

• HHS final research-misconduct rule and preamble
• 42 CFR Part 93 regulatory text
• NIH research-misconduct expectations
• NSF research-misconduct procedures

The contract was administered through the Acacia Center for Justice and supported a network of nearly 100 legal organizations serving about 20,000 children, according to the Associated Press. The children entered the United States without a parent or legal guardian available to care for them.

What the contract covered

The provider network offered rights presentations, legal screenings, referrals, help accessing shelter-related services and direct representation in immigration court. Those services can help children understand their cases and identify possible claims for immigration relief, including claims that may require filings before a hearing or before a child turns 18.

The Office of Refugee Resettlement, within the Department of Health and Human Services, oversees the federal Unaccompanied Children program. HHS budget documents describe access to legal services, rights information and child advocates among the services supported for children in ORR care, along with shelter, health care, education and case management.

The expiration does not establish that every child immediately lost a lawyer, and it does not by itself cancel an immigration-court hearing. The immediate issue is whether existing providers can continue work, whether cases will be transferred and how future services will be funded.

Why representation matters

Immigration cases are civil or administrative proceedings, and immigration courts generally do not provide government-appointed lawyers. The Justice Department’s Executive Office for Immigration Review says respondents may obtain representation at no cost to the government. EOIR guidance also says an immigration judge cannot appoint a legal practitioner or guardian ad litem for an unaccompanied juvenile.

That leaves children with pending hearings, possible asylum or other immigration claims, or cases approaching a child’s 18th birthday especially dependent on nonprofit providers, pro bono organizations or private counsel. A contract lapse can create uncertainty even when a hearing remains scheduled.

Providers report a funding dispute

Providers told reporters that more than $65 million had been withheld since December. KJZZ reported that some organizations faced layoffs, furloughs or reductions in services as payments were delayed.

The government said some funds were withheld because it requested information about services. Providers’ attorneys objected that the requests could implicate attorney-client privilege, KJZZ reported. The payment dispute and the contract expiration are related but separate: the funding dispute concerns payment for work providers say they already completed, while July 31 marked the end of the current engagement term documented in the provider notice.

What happens next

As of August 4, 2026, the materials reviewed for this report did not identify a replacement funding arrangement, replacement provider network or formal continuity plan. The Acacia provider notice described an engagement running from August 1, 2025, through July 31, 2026, with renewal contingent on further action.

Families, sponsors and advocates should watch official hearing notices, communications from a child’s attorney or accredited representative and announcements from HHS or immigration authorities. A change in representation may require an appropriate filing with the immigration court, and a contract expiration does not erase an existing hearing date or filing deadline. Any change in counsel, hearing date or deadline should be confirmed through an official court notice or a qualified legal provider.

The immediate national question is whether existing organizations can keep representing children while unpaid invoices are resolved and whether the federal government establishes a transition arrangement for children with active immigration cases.

Sources

• Associated Press report on the expired legal-aid deal
• HHS FY 2026 Congressional Justification
• EOIR Immigration Court Practice Manual
• KJZZ Fronteras Desk report

The HHS Office of Inspector General announced an active nationwide review on June 15, 2026, examining whether states conduct required Child Care and Development Fund, or CCDF, program-integrity activities. The review covers provider records involving enrollment, attendance and billing, along with the practices and challenges states encounter.

What changed in federal policy

The review follows a separate series of federal actions affecting how states may administer CCDF payments.

On January 5, the Department of Health and Human Services announced a proposed rollback of provisions from a 2024 CCDF rule. HHS said the earlier framework required states to pay providers prospectively, base payments on enrollment rather than verified attendance, and favor contracts over parent-directed vouchers. HHS also cited concerns about waste, fraud and abuse; those concerns were the agency’s stated rationale, not findings that every state or provider had engaged in misconduct.

The final rule, titled “Restoring Flexibility in the Child Care and Development Fund,” was published May 12 and took effect July 13, according to the Government Accountability Office. GAO said the rule rescinded requirements involving prospective payments, enrollment-based payments, certain contract-based services and a federal limit that had capped some family co-payments at 7% of family income.

The rule gives states more room to decide whether to use attendance-based billing, whether to pay providers after services are delivered and how to structure contracts and vouchers. That federal permission does not mean every state has changed its payment system or that providers nationwide are being paid on a new schedule.

What the inspector general is reviewing

The OIG project is an evaluation, not a fraud finding or enforcement action. Its stated objective is to assess the extent to which all states conduct specific CCDF integrity activities and what results those efforts produce.

Inspectors will review state activities involving provider records for child-care enrollment, attendance and billing. They also plan to identify efficient or effective approaches and the challenges states face when carrying out the selected checks.

For state agencies, the review places added importance on documenting how records are matched, how questionable billing is handled and whether controls work across different provider types. The OIG description does not say the review was triggered by a proven nationwide pattern of improper payments.

What providers and families may notice

Providers could face greater documentation demands if their state adopts attendance-based billing or pays after care is delivered. The practical effect may depend on each state’s systems, payment calendar, recordkeeping requirements and process for resolving discrepancies.

For families, the main near-term issue is watching for notices from a state child-care agency or provider. A state may change attendance-reporting procedures, verification steps or payment administration without changing who qualifies for CCDF assistance.

ACF guidance issued May 11 clarified the range of federally permitted options for parents selecting providers and services through CCDF. The revised framework preserves broader flexibility for parent-directed vouchers, but states still determine how those options operate locally.

What has not changed nationwide

The federal rule and guidance do not, by themselves, establish a nationwide change in family eligibility, subsidy amounts, access to care or provider reimbursement schedules. The rule does affect the federal framework for family co-payments, but the available sources do not establish how individual states will apply that change or whether families will see an immediate increase or decrease.

The rule also does not require every state to switch to attendance-based billing. Instead, it gives states more discretion over payment design while subjecting their enrollment, attendance and billing controls to active federal scrutiny.

What to watch next

The next important developments will be state implementation notices, additional ACF clarifications and the eventual findings or recommendations from the OIG review. Families and providers should look for guidance from their state child-care agency rather than assume that the federal rule has immediately changed local procedures.

The federal actions establish a direction: more state flexibility in CCDF payment methods, paired with closer attention to the records used to support those payments.

Sources

• HHS Office of Inspector General review
• Federal Register final CCDF rule
• Government Accountability Office review
• HHS Administration for Children and Families guidance

The lawsuit challenges a modified Health and Human Services Administration for Children and Families system-of-records notice for TANF data. The notice is not a court ruling and does not change TANF eligibility, benefit amounts or application procedures. Instead, it describes how records and verification information may be collected, used and disclosed for federal oversight and program-integrity reviews.

What the federal notice changed

The Federal Register notice became effective June 23, 2026. A new routine-use provision allowing certain disclosures for program-integrity reviews became effective July 23, 2026.

The notice says TANF data reported by state, territorial and tribal grantees may include family-level information such as county of residence, ZIP code, household size, case number and the type and amount of assistance received. Adult and minor-child records may include Social Security numbers, dates of birth, citizenship or immigration status, employment status, education information, work-activity hours and income.

Verification information obtained from TANF agencies, other HHS records or other government agencies may include names, addresses, Social Security numbers, dates of birth and detailed immigration-status information. The notice identifies the Department of Homeland Security and the Social Security Administration as examples of possible sources.

ACF says the system is used to determine whether grantees are ensuring recipient eligibility and to oversee compliance through activities including program-integrity reviews, audits, fraud investigations and monitoring. The new routine use allows disclosures to another federal or grantee agency, or to an entity engaged by ACF, to assist with those reviews, including verification of citizenship or immigration status. The notice says each proposed disclosure must be evaluated for legal permissibility.

What the states are asking the court to do

The states’ complaint seeks to stop the challenged data-sharing practices. It argues that the administration exceeded its authority, violated privacy protections and interfered with the states’ role in administering welfare programs. Those are allegations in the lawsuit, not findings by the court.

The states listed as joining the case are Arizona, California, Colorado, Connecticut, Delaware, Hawaii, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, Nevada, New Jersey, New Mexico, New York, Oregon, Rhode Island, Vermont, Virginia, Washington and Wisconsin, along with the District of Columbia. The governors of Kentucky and Pennsylvania also signed onto the suit, according to The Associated Press.

The defendants include federal officials and agencies responsible for the challenged records system, including HHS and ACF. ACF declined to comment to AP on August 3.

Why the dispute reaches across the country

TANF is a federal block-grant program administered through the 50 states, the District of Columbia, U.S. territories and tribal governments. The program provides more than $16 billion in federal grants, which states and other grantees may use for cash assistance, work programs, job training and related services for low-income families.

Because TANF records are collected and maintained through state, territorial and tribal programs, the case could affect how agencies respond to federal verification requests and what safeguards they apply when sharing recipient information.

What it means for recipients

The lawsuit concerns data access and governance. It does not announce a nationwide change to TANF eligibility, benefit amounts or application procedures. It also does not establish that the federal government is using TANF records for immigration enforcement.

The notice describes categories of information and possible disclosures; it does not mean every listed field will be released in every review. ACF says the records are subject to security, confidentiality and access controls.

What to watch next

The next important developments will be the federal response, any request for a temporary restraining order or preliminary injunction, and court decisions on whether the states can temporarily block the challenged data-sharing practices.

Later filings may clarify the states’ statutory and constitutional arguments, the administration’s interpretation of its oversight authority and how TANF agencies should handle federal information requests while the case proceeds.

Sources

• Federal Register: Modified TANF System-of-Records Notice
• Associated Press: States sue over access to social-service data
• HHS TAGGS: TANF assistance listing

The Department of Health and Human Services’ final rule, Restoring Flexibility in the Child Care and Development Fund, was published May 12, 2026, as 91 FR 25796. It took effect July 13, 2026. The rule changes federal requirements for how states, territories and tribal lead agencies administer the Child Care and Development Fund, or CCDF.

CCDF is the primary federal funding source for child-care assistance for low-income working families. It is generally administered through state, territorial and tribal systems, often using vouchers or certificates, rather than as one uniform national benefit.

What changed July 13

The final rule rescinded four requirements added in a March 2024 regulation:

• A federal limit requiring family copayments to stay at or below 7% of family income.
• Some requirements to provide direct child-care services through grants or contracts.
• A requirement that providers be paid prospectively, before or at the start of care, with limited exceptions.
• A requirement that providers generally be paid based on a child’s authorized enrollment rather than attendance, also subject to limited exceptions.

The Government Accountability Office confirmed that the rule was published May 12 and became effective July 13. GAO also summarized the same four rescissions as part of its procedural review of the rule.

What the rule does not do automatically

The rule restores discretion to program administrators. It does not order every state to raise copayments, switch to reimbursement payments or begin paying strictly according to attendance.

States and territories may continue policies that were previously required if they decide those policies work for their communities. The final rule says all four rescissions apply to states and territories, while only the repeal of the family-copayment limit applies to tribal lead agencies because tribal lead agencies were already generally exempt from the payment-practice requirements.

As a result, a federal regulatory change alone does not change the amount a subsidized family currently owes or the payment method a provider currently uses. The next practical decisions will come from the agency administering CCDF where the family lives or where the provider operates.

Copayments could vary more by state

The 2024 rule required a 7% family-income cap. The new rule removes that federal mandate and returns to statutory language saying that copayments cannot be a barrier to receiving child-care assistance.

A state may keep a 7% cap or adopt a lower limit, but the federal rule no longer requires every state to use that cap. HHS said that, as of March 2026, 31 states, the District of Columbia and five territories limited copayments to 7% or less of family income.

Families should watch for notices explaining whether their state is keeping its current cap, changing its fee schedule or revising how income and family size are considered. The rule itself is not a notice that a family’s bill will rise or fall.

Providers may see different payment schedules

States and territories may choose prospective payments, which are made before care is delivered, reimbursement-based payments made after care is provided, or a hybrid approach.

The federal statute still requires states and territories to pay providers in a timely manner. A change in payment method therefore cannot eliminate the obligation to make payments on time, although the timing, documentation and reconciliation process may differ from one jurisdiction to another.

Providers should confirm whether their state will continue prospective payments, return to reimbursement or create a new process for reconciling authorized care, attendance and payments. A September 2025 New America analysis found that states had taken widely different approaches before the new rule took effect. That analysis was based on information available at the time and warned that its state-by-state information might not be current or validated by state officials.

Attendance, enrollment and program controls

The rule gives states more options for separating payments from occasional absences while still meeting federal requirements. A state may use attendance or other verification tools, or may adopt another approach designed to preserve authorized care while addressing its own program-integrity concerns.

HHS has said the changes respond to concerns about waste, fraud and abuse. Those are the agency’s stated concerns and rationale; the final rule does not establish that fraud is occurring throughout the national CCDF program.

The HHS implementation guidance describes federally allowed options for parents and lead agencies, but the page also states that guidance generally lacks the force and effect of law. The controlling requirements are in the final regulation and in state, territorial and tribal implementation decisions.

Grants, contracts and vouchers

The rule also rescinds certain requirements that had directed states and territories to use grants or contracts for some direct services, including services involving infants and toddlers, children with disabilities and children in underserved geographic areas.

That does not guarantee that every family will have a new voucher option or that every state will abandon contracts. Instead, it gives lead agencies more discretion to decide how to combine direct services, grants, contracts and parent-directed assistance. Families should ask whether their voucher remains usable with their chosen provider and whether provider-choice or authorization rules are changing.

What families and providers should watch next

• Families: Check notices from the state, territory or tribal agency that administers your child-care assistance.
• Families: Ask whether your copayment, voucher authorization, provider-choice rules or attendance requirements are changing.
• Providers: Confirm the payment schedule, documentation requirements and any attendance or reconciliation process.
• Providers: Ask whether the state will continue prospective payments, return to reimbursement or use a hybrid model.
• Everyone: Treat federal guidance as implementation context and look to the final rule and local agency notices for binding requirements.

The central change is administrative flexibility, not a universal new benefit or immediate nationwide cost increase. Because states now have more room to choose among copayment, payment, grant, contract and voucher policies, child-care subsidy experiences may diverge more across the country.

Congressional action is another watch item. A Senate disapproval resolution concerning the rule was introduced and referred, but it was not described in the supplied record as enacted. Until the rule changes again or a state issues new instructions, families and providers should not assume that July 13 alone changed their current arrangements.

Sources

• 91 FR 25796, Restoring Flexibility in the Child Care and Development Fund
• GAO assessment of HHS’s CCDF final rule
• HHS/ACF Child Care and Development Fund Flexibilities

The Associated Press reported Monday, August 3, 2026, that the administration was considering replacing roughly 122 pages of federal Head Start performance standards with about a dozen pages of rules. People familiar with the internal deliberations told AP the approach would leave more decisions to states and local program operators. Any shift would depend on the final rule and its legal authority.

What the draft could change

According to AP’s reporting, the potential overhaul could affect child-to-teacher ratios, class sizes, curricula, medical, dental and vision screenings, family engagement, home visits, safety practices and discipline involving children with disabilities.

AP also reported that an early draft included additional documentation for some homeless or unemployed parents and a possible restriction involving undocumented parents. It was unclear whether those provisions would remain, so they should not be treated as settled policy.

The Department of Health and Human Services said a rule was expected during the week of August 3. At the time of AP’s report, however, the broader proposal was not public. Until HHS publishes a notice and completes the rulemaking process, current Head Start requirements remain in effect.

Why families and providers are watching

Head Start serves more than half a million low-income babies, toddlers and preschoolers nationwide. The program provides early education, developmental screenings, health referrals and support for families.

Any change in federal standards could affect how programs organize classrooms, identify health or developmental needs, work with families and respond to children with disabilities. The practical effects would depend on the final language, how states and local operators respond, and whether courts or other legal challenges delay implementation.

Families should continue using existing Head Start enrollment channels and current eligibility rules unless HHS formally announces a change. Providers should continue following their obligations under 45 CFR Part 1302 and the Head Start Act.

A separate wage-and-benefits proposal

The broader contemplated overhaul is separate from an earlier proposed rule published by the Administration for Children and Families on May 12, 2026. That proposal, titled Restoring Flexibility To Support Head Start Program Access, would remove wage and benefit requirements added to the Head Start performance standards in 2024.

ACF estimates that the proposal, if finalized, would reduce future program expenditures by approximately $2.1 billion. That is the agency’s projection, not a completed reduction in program spending or staff compensation.

The current personnel rules require benefits-related changes by August 1, 2028, and wage-related changes by August 1, 2031. The wage provisions include pay scales, progress toward comparability with public preschool teachers and a salary level generally sufficient to cover basic needs. Those requirements remain current unless changed through formal rulemaking.

What happens next

A federal regulatory-planning record identifies a separate broader Head Start notice of proposed rulemaking under RIN 0970-AD30. The record describes the effort as being in the proposed-rule stage and lists November 2026 as its anticipated publication month. That is a planning estimate, not a publication deadline or final-action date.

If HHS publishes the broader proposal, the notice should identify the regulatory text, legal rationale and public-comment deadline. Federal law requires at least 30 days for public comment on a proposed rule. The agency could revise the proposal before issuing a final rule, and implementation could face administrative or court delays.

For now, the administration has signaled a direction toward fewer federal Head Start requirements and more state and local flexibility. It has not completed a regulatory change.

Sources

• Associated Press report on the contemplated Head Start overhaul
• Federal Register wage-and-benefits proposed rule
• Reginfo record for RIN 0970-AD30
• HeadStart.gov personnel standards

The placements included hotels, state and county offices, and other unlicensed facilities that were not designed to care for children. The report offers a national snapshot, but its figures are based on state questionnaire responses and follow-up information, not a complete national administrative dataset. They should not be treated as a current 2026 placement count.

What the review counted

Forty-nine state agencies responded to the HHS Office of Inspector General questionnaire, although not all supplied every requested data point. Forty-two agencies reported using temporary emergency placements, and 34 tracked their use well enough to report 15,705 stays.

The report defines a stay as one or more consecutive nights. The total does not equal the number of children because some children had multiple stays. One state agency, for example, reported that a child was housed in a hotel on five separate occasions during the audit period.

Thirty agencies provided enough information to identify 9,045 children involved. Eight agencies said they did not keep records to track children in temporary emergency placements, while seven reported that they did not use them. Two agencies did not respond.

Hotels and offices were among the settings used

Seventeen state agencies reported 1,922 hotel-room stays. Twenty-two agencies reported 2,698 stays in state or county offices. Sixteen agencies reported 4,412 stays in other unlicensed settings, including emergency shelters, transitional centers and cabins in state parks. For 6,673 reported stays, the available information was not detailed enough to identify the type of facility.

The average reported stay was seven days, but the range was wide. The longest reported stay lasted 251 days in a hotel. Fifty-nine percent of the stays lasted four days or less, while 14% lasted 11 days or longer. The report said stay-length information was incomplete for some states.

The largest age group in the child-level analysis was teenagers ages 15 to 17. States also reported 1,496 children age 5 or younger in temporary emergency placements.

Placement shortages drove the problem

State agencies told the inspector general that the central difficulty was finding licensed homes and facilities able to serve children with complex behavioral, mental-health or medical needs. Agencies also reported particular difficulty placing older children.

Other factors cited by states included disruptions tied to the COVID-19 public health emergency and the effects of illicit drug use on the needs of children entering foster care. The report frames the risks as concerns about suitability, safety, health and well-being, including difficulty maintaining therapy, enrolling children in school and providing adequate privacy, activities and living space.

The review did not find that every state used hotels or offices, and it did not say that all temporary placements were unlawful. The inspector general described them as unlicensed settings not designed for foster care and noted that 40 responding state agencies said their laws did not specifically prohibit their use.

Some placements were excluded from the totals

The questionnaire also asked about hospitals, detention centers and jails. Some agencies said they used those settings in certain circumstances, including instances in which children remained in hospitals beyond the medically necessary period because no suitable placement was available. But the agencies generally did not track those stays separately, so the inspector general excluded them from the totals it presented.

Federal officials agreed to improve tracking

The inspector general recommended that the Administration for Children and Families work with states to improve data collection and reporting on temporary emergency placements. ACF concurred with the recommendation.

In written comments dated June 5, 2026, ACF said it was testing approaches to expand data collection and that the information gathered could inform future federal guidance. ACF also cited its Home for Every Child Initiative, which encourages states to support children in safe, stable and appropriate environments.

That response is not the same as a completed national tracking system or a federal policy change already in effect.

What to watch next

The report’s questionnaire and follow-up work reflected information available through January 2025, and the audit itself was conducted from March 2024 through May 2026. The report therefore does not establish whether temporary emergency placements have increased or declined since June 2023.

The most important follow-up will be whether ACF and the states establish clearer definitions, comparable reporting and measurable progress in reducing unlicensed emergency placements.

Readers and child-welfare advocates should also watch for changes in the supply of licensed foster homes, the use of kinship care, access to behavioral-health services and specialized support for older children and children with complex needs. Better data would help show where shortages and repeat placements are concentrated, but the July 2026 report does not provide a new national count for current placements.

Sources

• HHS Office of Inspector General audit report
• KFF Health News context report

This order does not instantly rewrite pesticide rules or change store-shelf labels by itself. Instead, it directs prioritization for reviews and calls for new research and evaluation frameworks that can influence how future regulatory decisions are supported.

What EO 14414 did, in plain English

EO 14414 directs federal agencies to work on five connected tracks:

1) EPA pesticide registration prioritization tied to the order’s broader farm-resilience goals.

2) EPA review of registered pre-harvest desiccation pesticide uses focused on safety expectations and accurate labeling.

3) HHS/USDA/EPA development of a “cumulative exposure” framework using “New Approach Methodologies” (a shift toward modern evaluation tools and methods).

4) HHS/NIH launch of a “grand prize challenge” to advance cumulative-exposure evaluation, diagnosis, and treatments.

5) ARPA-H prioritization of technologies intended to reduce reliance on conventional chemical crop protection tools.

The order also directs USDA to expand a regenerative agriculture pilot program and share results more broadly.

EPA’s new priorities: registrations and pre-harvest desiccation review

For farmers and the farm-supply chain, the most immediate relevance is how EPA decides what to review first—and what kinds of evidence it emphasizes.

EO 14414 directs EPA to prioritize certain pesticide registration actions. It also directs EPA to conduct a focused review of registered pre-harvest desiccation pesticide uses, with an emphasis on supporting safety and accurate labeling.

In practical terms: this is designed to shift agency workload and attention toward specific decision points—without claiming that any particular product is automatically approved, restricted, or banned immediately.

The core scientific shift: cumulative chemical exposure frameworks

At the center of EO 14414 is a direction to develop an approach for evaluating cumulative exposure across chemical classes in the food supply.

The order directs HHS, USDA, and EPA to develop a research and evaluation framework using New Approach Methodologies. The phrase matters because it signals a move toward modern testing and evaluation approaches rather than relying solely on traditional product-by-product assessments.

It also includes accountability language: implementation is described as consistent with applicable law, and the order states it does not create enforceable rights for private parties.

NIH’s “grand prize” and ARPA-H: accelerating tools and alternatives

EO 14414 also targets innovation pathways.

It instructs HHS/NIH to launch a grand prize challenge focused on methods for cumulative-exposure evaluation and downstream clinical directions—how cumulative effects can be assessed and how that information could support diagnosis and treatments.

Separately, the order directs ARPA-H to prioritize projects involving technologies intended to reduce reliance on conventional chemical crop protection tools. That’s different from regulation: it’s about building or accelerating tools that could, later, change real-world farming options.

USDA regenerative agriculture pilot expansion

USDA is also directed to expand a regenerative agriculture pilot program. The real-world impact will depend on the follow-on details—such as which partners qualify, which practices are eligible, and how results are measured and shared.

EO 14414 frames the pilot as part of a broader resilience strategy, but readers should watch for the program parameters that determine who can participate and what outcomes are tracked.

What this means for consumers and farm operators—and what it does not do yet

What it could change over time: EPA’s evidence expectations and review priorities, plus the research methods agencies use when evaluating how risks combine across chemical exposures.

What it does not do on day one: It does not function like an automatic ban, an immediate mass relabeling order, or a guaranteed new threshold for any specific chemical. The order’s own cautions and “consistent with applicable law” language limit how far it can be treated as a direct promise of a near-term regulatory outcome.

For timing context: EO 14414 was signed June 25, 2026. The presidential documents were posted with a June 29, 2026 filing and a June 30, 2026 Federal Register header.

What to watch next (in the coming weeks/months)

To track whether this shifts actual regulatory or research priorities, watch for:

• EPA follow-through on registration-review prioritization and the desiccation-related safety and labeling review work.

• USDA pilot expansion details (scope, participation, and how results will be reported).

• NIH grand prize challenge milestones—including timelines, criteria, and how teams qualify.

• ARPA-H project announcements tied to technologies meant to reduce reliance on conventional chemical crop protection tools.

EO 14414 is best understood as a federal “direction-setter” for how agencies allocate research energy and frame risk evaluation—steps that can matter for future decisions well before any single headline regulatory action.

Sources

• White House: Executive Order 14414
• HHS.gov Press Room: EO 14414 overview

This is an application opportunity, not a final award list. States, local providers, schools, nonprofits, hospitals, and other eligible organizations still have to apply and compete for the money before any funds reach local programs.

What the grants are meant to cover

HHS said the new round supports substance use disorder treatment, overdose prevention and response, mental health and suicide prevention, trauma-informed care, integrated care, recovery supports, first responder training, privacy education, and workforce development. Reuters independently confirmed the same-day announcement and reported that the funding spans 15 programs.

The largest single opportunity is $68.2 million for medication-assisted treatment tied to opioid use disorder. Other programs include school mental-health infrastructure, trauma services for children and youth, campus suicide prevention, community overdose prevention, recovery support services, integrated physical and behavioral health care, and education tied to federal behavioral-health privacy rules.

Why this matters nationally

For households, the practical question is whether local systems can use federal grants to expand access to care that can be hard to find or slow to reach. In many places, that means more treatment slots, better overdose response, stronger school mental-health support, and more training for workers who deal with behavioral-health crises.

For schools, the grants could help districts and colleges build or strengthen mental-health programs, train staff, and connect students to services earlier. For public-health agencies and community nonprofits, the money could help support recovery programs, prevention work, and integrated care models that try to keep people from falling through the cracks.

The timing matters. A funding announcement does not mean services change overnight. Applicants still have to submit proposals, HHS has to review them, and awards have to be finalized before communities see the impact. The next major development will be the list of grantees and the breakdown of how much each program receives.

Readers should watch for follow-up notices from HHS and SAMHSA naming awardees, along with any state-by-state or program-by-program allocations. Those later releases will show which communities are likely to see the first measurable impact from this round of federal behavioral-health funding.

Sources

• U.S. Department of Health and Human Services press release: SAMHSA announces $281 million in funding opportunities
• Reuters report syndicated by Investing.com on the SAMHSA grant announcement

The key point for hospitals, clinics, distributors, and manufacturers is that this is a phased transition, not an immediate blanket stop. The declaration for drugs and biological products will terminate on June 29, 2027. The medical-device declarations end sooner, on December 26, 2026. That split timeline matters for purchasing, inventory, labeling, documentation, and product planning.

Two sunset dates, not one

HHS said the advance notice is meant to give manufacturers, healthcare providers, health systems, distributors, and patients time to move away from products covered only by the COVID declarations. The agency also said it will keep working with manufacturers on traditional pathways for products seeking approval, clearance, or licensure.

The FDA’s EUA framework says emergency use authorization is a temporary authority used during emergencies when there are no adequate, approved, and available alternatives. The current HHS action does not end that framework itself. It starts the formal end of the COVID-specific declarations that kept some products available under emergency authority.

What changes for providers and suppliers

For health systems and suppliers, the practical work is mostly compliance. Products that rely only on the emergency declarations may need replacement plans before the shorter device deadline. Purchasing teams may need to confirm whether a product is available through an ordinary FDA pathway, while compliance and inventory teams may need to update records before old authorization language becomes obsolete.

For manufacturers, the message is straightforward: emergency coverage is no longer a long-term business plan. Companies that want continued market access will need to rely on standard FDA approval, clearance, or licensure pathways where appropriate.

Why this matters now

Patients should not expect a sudden disruption across the board. The notices create room for an orderly transition, and the timelines are designed to avoid a hard stop. Still, the shorter device deadline means some facilities will have to act sooner than others.

In short, HHS has begun the formal unwind of the last COVID-era EUA declarations. The change is gradual, the deadlines are different, and the operational work starts now rather than later.

Sources

• HHS press release: HHS ends COVID-19 emergency-use authorizations
• Federal Register notice: termination of drug and biologic emergency-use declaration
• FDA Emergency Use Authorization framework page
• AHA News: HHS to end emergency authorization for COVID-19 drugs and medical devices

The White House signed Executive Order 14414 on June 25, 2026, putting regenerative agriculture inside a broader food-supply and public-health frame. The order links farm modernization, soil health and the administration’s Make America Healthy Again agenda, but it does not itself create a new nationwide rule. It is a directive to federal agencies, with implementation still subject to existing law and available funding.

What USDA, HHS and EPA must do

The order tells USDA to expand the current Regenerative Agriculture Pilot Program, share results more broadly and look for public-private partnerships that can increase capacity for farmers interested in these practices. It directs EPA to prioritize registration of alternative crop-protection tools and review pre-harvest desiccation data for safety and labeling. It also tells USDA, HHS and EPA to develop research and evaluation frameworks on cumulative chemical exposure in the food supply.

HHS says it will add a National Institutes of Health prize challenge and direct ARPA-H toward technologies that reduce reliance on chemical crop protection tools. The department also released an ASPE issue brief the same day saying regenerative agriculture may improve food quality and reduce harmful exposures, while noting that more research is needed.

Why it matters

For farmers and food companies, the immediate effect is not a new mandate. The practical question is whether the order changes grant priorities, research funding, technical assistance or later rulemaking. Reuters also reported that the White House framed the move as an effort to strengthen the security of the U.S. food supply.

What to watch next

The next signs of impact will come from USDA, HHS and EPA: program guidance, research notices, prize-challenge details and any later regulatory review. Until then, the order should be read as the start of implementation, not the final policy result. Farmers, agribusinesses and consumers will get a clearer picture only when agencies turn the directive into specific actions.

Sources

• White House executive order: Advancing Regenerative Agriculture and Strengthening American Farm Resilience
• HHS press release on regenerative agriculture
• HHS ASPE issue brief on regenerative agriculture and population health
• Reuters report via Investing.com on the White House agriculture order

On June 29, 25 states and the District of Columbia sued, arguing CMS’s new limits on the medical-frailty exemption go beyond the law and could push states toward more paperwork-heavy systems that risk coverage losses for eligible people.

What states have to do next

HHS says states must implement the community-engagement requirement no later than Jan. 1, 2027. The complaint says states must also begin sending notices to enrollees by Aug. 31, 2026, giving Medicaid agencies a tight window to finish eligibility, verification, and notice systems.

For Medicaid enrollees and state agencies, the practical issue is whether exemption checks will be clear enough to keep eligible people from getting caught in avoidable paperwork problems before the rollout.

Sources

• CMS press release: Nationwide framework to implement Medicaid work requirements
• HHS Guidance Portal: Medicaid Program; Community Engagement Requirement for Certain Individuals
• Associated Press: Democrats in half of states sue Trump administration over Medicaid work rules
• Multi-state lawsuit complaint: Medicaid work requirements

That matters because emergency-use authorizations are the legal tool FDA uses to allow unapproved products, or unapproved uses of approved products, during an emergency when there are no adequate approved and available alternatives. HHS said the public-health conditions that justified those COVID-era declarations no longer exist.

An orderly unwind, not a sudden stop

HHS said the notice periods are meant to give manufacturers, health systems, distributors, providers and patients time to move away from products authorized only under the COVID EUA declarations. In practical terms, that can affect purchasing, inventory planning, labeling and documentation, especially for facilities that still have emergency-authorized products in stock or in procurement pipelines.

The department also said HHS and FDA will keep working with manufacturers on the normal pathways for products that seek traditional approval, clearance or licensure. Ending the declarations is not the same as an immediate ban on every COVID-era product, and it is not a blanket safety finding. Some products may continue under ordinary FDA pathways if they qualify.

What to watch next

The next question is product-specific: which drugs, biologics, tests and devices move into standard review, and which ones fall off the emergency-only track as the notice periods run out? HHS said it will publish the terminations in the Federal Register and send the required congressional notices.

For patients, the likely result is a gradual transition rather than a sudden disruption. For providers and distributors, the key task is to identify which items are still covered only by emergency authority and plan replacements before the deadlines arrive.

Sources

• HHS press release: HHS ends COVID-19 emergency-use authorizations
• Health.gov mirror: HHS Secretary Kennedy signs COVID-19 EUA declaration terminations
• FDA background: Emergency Use Authorization framework